Home LiteratureArticle Details
PMID: 23223361 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells.

Blood ·Vol. 121 ·No. 9 ·2013-02-28 ·Pages 1595-603

Kinnunen T, Chamberlain N, Morbach H, Choi J, Kim S, Craft J, Mayer L, Cancrini C, Passerini L, Bacchetta R, Ochs HD, Torgerson TR, Meffre E

Abstract

Regulatory T cells (Tregs) play an essential role in preventing autoimmunity. Mutations in the forkhead box protein 3 (FOXP3) gene, which encodes a transcription factor critical for Treg function, result in a severe autoimmune disorder and the production of various autoantibodies in mice and in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) patients. However, it is unknown whether Tregs normally suppress autoreactive B cells. To investigate a role for Tregs in maintaining human B-cell tolerance, we tested the reactivity of recombinant antibodies isolated from single B cells isolated from IPEX patients. Characteristics and reactivity of antibodies expressed by new emigrant/transitional B cells from IPEX patients were similar to those from healthy donors, demonstrating that defective Treg function does not impact central B-cell tolerance. In contrast, mature naive B cells from IPEX patients often expressed autoreactive antibodies, suggesting an important role for Tregs in maintaining peripheral B-cell tolerance. T cells displayed an activated phenotype in IPEX patients, including their Treg-like cells, and showed up-regulation of CD40L, PD-1, and inducibl T-cell costimulator (ICOS), which may favor the accumulation of autoreactive mature naive B cells in these patients. Hence, our data demonstrate an essential role for Tregs in the establishment and the maintenance of peripheral B-cell tolerance in humans.

MeSH Terms
Autoimmune Diseases/immunology,pathology Autoimmunity/immunology B-Lymphocytes/cytology,immunology,pathology Case-Control Studies Cells, Cultured Child, Preschool Humans Infant Infant, Newborn Lymphocyte Count Peripheral Tolerance/immunology Syndrome T-Lymphocytes, Regulatory/cytology,immunology,pathology,physiology X-Linked Combined Immunodeficiency Diseases/immunology,pathology
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Kinnunen Tuure
Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06511, USA.
Chamberlain Nicolas
Morbach Henner
Choi Jinyoung
Kim Sangtaek
Craft Joseph
Mayer Lloyd
Cancrini Caterina
Passerini Laura
Bacchetta Rosa
Ochs Hans D
Torgerson Troy R
Meffre Eric
References (50)
50 references, click to expand
  1. Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy.
    J Clin Invest. 2012 Jun;122(6):2141-52 PMID: 22622038
  2. Predominant autoantibody production by early human B cell precursors.
    Science. 2003 Sep 5;301(5638):1374-7 PMID: 12920303
  3. Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans.
    Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11554-9 PMID: 21700883
  4. Foxp3 occupancy and regulation of key target genes during T-cell stimulation.
    Nature. 2007 Feb 22;445(7130):931-5 PMID: 17237765
  5. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.
    Nat Immunol. 2007 Mar;8(3):277-84 PMID: 17220892
  6. Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells.
    J Allergy Clin Immunol. 2010 Dec;126(6):1242-51 PMID: 21036387
  7. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.
    Int Immunol. 2007 Apr;19(4):345-54 PMID: 17329235
  8. Regulatory T cell lineage specification by the forkhead transcription factor foxp3.
    Immunity. 2005 Mar;22(3):329-41 PMID: 15780990
  9. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.
    J Clin Invest. 2011 Sep;121(9):3635-44 PMID: 21804190
  10. Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.
    Eur J Immunol. 2011 Apr;41(4):1120-31 PMID: 21400500
  11. Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4+ effector cells that are resistant to regulatory T cell activity.
    J Autoimmun. 2008 Sep;31(2):98-109 PMID: 18539433
  12. Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity.
    Front Immunol. 2012 Jul 31;3:211 PMID: 23060872
  13. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies.
    J Autoimmun. 2010 Nov;35(3):265-8 PMID: 20650610
  14. Bruton's tyrosine kinase is essential for human B cell tolerance.
    J Exp Med. 2004 Oct 4;200(7):927-34 PMID: 15466623
  15. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells.
    J Immunol. 2005 Oct 1;175(7):4180-3 PMID: 16177055
  16. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion.
    Immunity. 2011 Jan 28;34(1):108-21 PMID: 21215658
  17. Activated CD4+CD25+ T cells selectively kill B lymphocytes.
    Blood. 2006 May 15;107(10):3925-32 PMID: 16418326
  18. FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome.
    N Engl J Med. 2009 Oct 22;361(17):1710-3 PMID: 19846862
  19. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo.
    Nat Immunol. 2009 Sep;10(9):1000-7 PMID: 19633673
  20. An essential role for Scurfin in CD4+CD25+ T regulatory cells.
    Nat Immunol. 2003 Apr;4(4):337-42 PMID: 12612581
  21. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.
    Nature. 2007 Feb 22;445(7130):936-40 PMID: 17237761
  22. Control of regulatory T cell development by the transcription factor Foxp3.
    Science. 2003 Feb 14;299(5609):1057-61 PMID: 12522256
  23. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.
    Nat Genet. 2001 Jan;27(1):20-1 PMID: 11137993
  24. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity.
    J Allergy Clin Immunol. 2008 Dec;122(6):1105-1112.e1 PMID: 18951619
  25. Altered B cell development and anergy in the absence of Foxp3.
    J Immunol. 2010 Aug 15;185(4):2147-56 PMID: 20639490
  26. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions.
    Nat Med. 2011 Jul 24;17(8):983-8 PMID: 21785430
  27. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development.
    Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6659-64 PMID: 16617117
  28. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.
    J Exp Med. 2000 Dec 4;192(11):1553-62 PMID: 11104798
  29. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
    Nat Immunol. 2003 Apr;4(4):330-6 PMID: 12612578
  30. Helios expression is a marker of T cell activation and proliferation.
    PLoS One. 2011;6(8):e24226 PMID: 21918685
  31. Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability.
    J Allergy Clin Immunol. 2011 Dec;128(6):1376-1379.e1 PMID: 22000569
  32. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion.
    J Exp Med. 2007 Mar 19;204(3):645-55 PMID: 17312005
  33. B cells and professional APCs recruit regulatory T cells via CCL4.
    Nat Immunol. 2001 Dec;2(12):1126-32 PMID: 11702067
  34. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.
    Nat Immunol. 2007 Feb;8(2):191-7 PMID: 17136045
  35. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.
    Diabetes. 2005 Jan;54(1):92-9 PMID: 15616015
  36. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production.
    J Exp Med. 2000 Dec 4;192(11):1545-52 PMID: 11104797
  37. Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
    J Clin Invest. 2006 Jun;116(6):1713-22 PMID: 16741580
  38. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy.
    J Exp Med. 2004 Aug 2;200(3):277-85 PMID: 15280421
  39. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.
    J Exp Med. 2007 Jul 9;204(7):1583-93 PMID: 17562816
  40. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans.
    Immunity. 2008 Nov 14;29(5):746-57 PMID: 19006693
  41. Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus.
    J Immunol. 2009 Aug 1;183(3):1518-22 PMID: 19570829
  42. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype.
    Blood. 2007 Oct 15;110(8):2983-90 PMID: 17644734
  43. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.
    J Exp Med. 2004 Apr 5;199(7):971-9 PMID: 15067033
  44. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells.
    Immunity. 2002 Apr;16(4):535-46 PMID: 11970877
  45. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor.
    Cell. 1996 Oct 18;87(2):319-29 PMID: 8861915
  46. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells.
    J Immunol. 2010 Apr 1;184(7):3433-41 PMID: 20181882
  47. Cracking the BAFF code.
    Nat Rev Immunol. 2009 Jul;9(7):491-502 PMID: 19521398
  48. Cutting edge: CD25+ regulatory T cells prevent expansion and induce apoptosis of B cells specific for tissue autoantigens.
    J Immunol. 2008 Oct 1;181(7):4447-51 PMID: 18802046
  49. Impaired early B cell tolerance in patients with rheumatoid arthritis.
    J Exp Med. 2005 May 16;201(10):1659-67 PMID: 15897279
  50. Foxp3+ follicular regulatory T cells control the germinal center response.
    Nat Med. 2011 Jul 24;17(8):975-82 PMID: 21785433
Article Info
Journal
Blood
Abbr.
Blood
ISSN
1528-0020
Published
2013-02-28
Epub
2012-00-05
Pages
1595-603
Language
English
Region
United States
NLM ID
7603509
PMCID
PMC3587322
Subset
IM
Grants
NIAID NIH HHS · AI095848 · United States
NIAID NIH HHS · R01 AI071087 · United States
NIAID NIH HHS · P01 AI061093 · United States
NIAID NIH HHS · AI082713 · United States
NIAID NIH HHS · U19 AI082713 · United States
NIAID NIH HHS · AI061093 · United States
NIAMS NIH HHS · T32 AR007107 · United States
NIAID NIH HHS · AI071087 · United States
NIAID NIH HHS · R21 AI095848 · United States
Telethon · TGT11A04 · Italy
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com